MUNICH, Germany--(BUSINESS WIRE)--The Advalytix product team of Olympus is launching a certification program for flow cytometry facilities who have demonstrated > 90% success rate of placing single cells into the reaction sites on Advalytix’ 1µl AmpliGrid PCR slides. Among the first to achieve certification are flow cytometry facilities located at the Brigham & Women’s Hospital, Boston, MA; UMass Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; Creighton University, Omaha, NE; Duke University Human Vaccine Institute, Durham, NC; UNC at Chapel Hill; MD Anderson Cancer Center, Houston, TX; NIH’s NHLBI and NCI, Bethesda, MD; the Gladstone Institutes, San Francisco, CA, Stanford University, Palo Alto, CA and the German Rheumatism Research Center, Berlin, Germany.
